Collins Stewart: Masimo's '11 Ends Well and '12 Guidance May Prove Conservative

Loading...
Loading...
According to a research report published today by Collins Stewart, Masimo Corporation's
MASI
4Q11 results provided initial 2012 guidance that were in line with consensus. In the report, Masimo explained further, “Following a couple quarters of downward revisions, we view this as a positive. Rainbow revenue rebounded during the quarter (+16% yr/yr), adjusted gross margin was a bit better than expected, and operating expenses were under control. For 2012, management expects continued share gains, especially on the back of record contract bookings signed in 4Q11. With a significant amount of recurring revenue, ongoing share gains, improving margins, and a sizable market opportunity with its Rainbow platform, we view Masimo as our favorite small cap stock and reiterate our Buy rating.” Collins Stewart maintains its $26 PT on Masimo, which closed yesterday at $21.59.
Market News and Data brought to you by Benzinga APIs
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorReiterationAnalyst RatingsCollins StewartHealth CareHealth Care Equipment
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...